Skip to main content
. 2019 Jan 24;41(3):1549–1559. doi: 10.3892/or.2019.6983

Figure 10.

Figure 10.

miRNA-223 may be an anticancer gene in NSCLC through the PI3K/AKT pathway by targeting EGFR. NSCLC, non-small cell lung cancer; EGFR, epidermal growth factor receptor.